Z. Harsanyi

发表

Comparative Efficacy and Safety of Controlled‐Release Morphine Suppositories and Tablets in Cancer Pain

D. Moulin, F. Laberge, L. Provencher, 1998, Journal of clinical pharmacology.

Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation.

E. Bruera, R. Fainsinger, K. Spachynski, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain

N. Hagen, N. Babul, Z. Harsanyi, 1994, Cancer.

Steady‐State Pharmacokinetics of Hydromorphone and Hydromorphone‐3‐Glucuronide in Cancer Patients After Immediate and Controlled‐Release Hydromorphone

N. Hagen, N. Babul, Z. Harsanyi, 1995, Journal of clinical pharmacology.

Comparison of the efficacy, safety, and pharmacokinetics of controlled release and immediate release metoclopramide for the management of chronic nausea in patients with advanced cancer

E. Bruera, K. Spachynski, T. Maceachern, 1994, Cancer.

Long-Term Safety and Clinical Effectiveness of Controlled-Release Metoclopramide in Cancer-Associated Dyspepsia Syndrome: A Multicentre Evaluation

Jonathan Wilson, Z. Harsanyi, A. Darke, 2002, Journal of palliative care.

Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen.

E. Bruera, M. Suarez‐Almazor, N. Babul, 1996, Journal of pain and symptom management.

A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer.

E. Bruera, N. Babul, Z. Harsanyi, 2000, Journal of pain and symptom management.

Efficacy of Uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids.

L. Boulet, H. Kreisman, J. Côté, 1995, American journal of respiratory and critical care medicine.

Evaluation of dosing guidelines for use of controlled-release codeine in chronic noncancer pain.

A. J. Clark, D. Moulin, A. Russell, 2003, Pain research & management.

Efficacy of a novel biphasic controlled-release methylphenidate formula in adults with attention-deficit/hyperactivity disorder: results of a double-blind, placebo-controlled crossover study.

L. Hechtman, U. Jain, M. Weiss, 2007, The Journal of clinical psychiatry.

A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinence.

J. Corcos, S. Radomski, Z. Harsanyi, 2004, Clinical therapeutics.

Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.

L. Hechtman, U. Jain, M. Weiss, 2007, Journal of child and adolescent psychopharmacology.

Controlled-release codeine is equivalent to acetaminophen plus codeine for post-cholecystectomy analgesia

D. Tong, F. Chung, Z. Harsanyi, 2004, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Efficacy and safety of controlled-release oxycodone and standard therapies for postoperative pain after knee or hip replacement.

M. Winemaker, Z. Harsanyi, A. Darke, 2005, Canadian journal of surgery. Journal canadien de chirurgie.

Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial

A. Sandler, N. Babul, Z. Harsanyi, 1995, Pain.

A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis.

C. Thorne, A. Beaulieu, J. Eisenhoffer, 2008, Pain research & management.

A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain.

P. Peloso, A. J. Clark, A. Beaulieu, 2007, Clinical therapeutics.

Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.

E. Bruera, E. Pituskin, R. Fainsinger, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Steady‐State Pharmacokinetic Evaluation of a Novel, Controlled‐Release Morphine Suppository and Subcutaneous Morphine in Cancer Pain

E. Bruera, R. Fainsinger, K. Spachynski, 1995, Journal of clinical pharmacology.

The dose-response relationship of controlled-release codeine (Codeine Contin) in chronic cancer pain.

W. Thorpe, D. Moulin, Z. Harsanyi, 1994, Journal of pain and symptom management.

A double‐blind randomized dose‐response study comparing daily doses of 5, 10 and 15 mg controlled‐release oxybutynin: balancing efficacy with severity of dry mouth

Z. Harsanyi, A. Darke, C. Andreou, 2006, BJU international.

Twice-daily versus once-daily morphine sulphate controlled-release suppositories for the treatment of cancer pain

E. Bruera, Z. Harsanyi, A. Darke, 1999, Supportive Care in Cancer.

Randomized evaluation of controlled-release codeine and placebo in chronic cancer pain.

P. Sloan, N. Babul, Z. Harsanyi, 1995, Journal of pain and symptom management.

Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee.

N. Bellamy, P. Peloso, W. Bensen, 2000, The Journal of rheumatology.

Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study.

I. Sutton, J. Eisenhoffer, M. Csanádi, 2013, Pain research & management.

Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain.

N. Hagen, J. Eisenhoffer, Z. Harsanyi, 2005, Journal of pain and symptom management.

Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: a randomized controlled trial.

P. Peloso, B. Haraoui, J. Wade, 2008, Pain research & management.

Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain.

S. Rashiq, A. Gordon, A. J. Clark, 2010, Pain research & management.

Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration.

J. Stewart, J. Latreille, F. Viguié, 1995, Journal of pain and symptom management.

Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase.

S. Rashiq, A. Gordon, N. Buckley, 2010, Clinical therapeutics.

The Pain and Sleep Questionnaire three-item index (PSQ-3): a reliable and valid measure of the impact of pain on sleep in chronic nonmalignant pain of various etiologies.

L. Ayearst, Z. Harsanyi, K. Michalko, 2012, Pain research & management.

Cognitive and behavioral effects of multilayer-release methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder.

R. Schachar, J. Crosbie, A. Ickowicz, 2008, Journal of child and adolescent psychopharmacology.

Efficacy of 12 Hourly Controlled-Release Condeine Compared with as Required Dosing of Acetaminophen Plus Codeine in Patients with Chronic Low Back Pain

P. Lacouture, Z. Harsanyi, A. Darke, 1997 .

Opioid use following the introduction of an extended-release oxycodone formulation with tamper-resistant properties: Prospective historical chart review in methadone-maintained patients.

B. Setnik, Z. Harsanyi, P. Geoffroy, 2016, Journal of Opioid Management.

PAIN, FEAR OF PAIN, AND DISABILITY: A REPEATED MEASURES ANALYSIS WITH A TERTIARY TREATMENT SAMPLE

M. P. Abrams, J. Sibley, R. Carleton, 2016 .

Analysis of the Analgesic Efficacy of Acetaminophen 1000 mg, Codeine Phosphate 60 mg, and the Combination of Acetaminophen 1000 mg and Codeine Phosphate 60 mg in the Relief of Postoperative Pain

J. Kellam, S. Gertzbein, M. Tile, 1986, Pharmacotherapy.